/Companies

Ally Therapeutics

Cambridge, US · Founded 2018 · Delaware corporation · 2 known investors

Find your way into Ally Therapeutics

Sign up to see every warm intro you have to Ally Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ally Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

TL
Tina LiuNamed on SEC filing
DC
David CordoNamed on SEC filing
EW
Erica WhittakerNamed on SEC filing
SGSteve Gillis
Steve GillisNamed on SEC filingManaging Director at ARCH Venture Partners

Board

BM
Bob MoreBoard directorManaging Director at Alta Partners

Investors · 2

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2019

▶$10MraisedAug 2019 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Tina LiuExecutive Officer, Director
  • David CordoExecutive Officer
  • Bob MoreDirector
  • Erica WhittakerDirector
  • Steve GillisDirector
Offering amount
$11M
Amount sold
$10M
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Ally Therapeutics's investors?
Ally Therapeutics's investors include Alta Partners, ARCH Venture Partners.
How much funding has Ally Therapeutics raised?
Ally Therapeutics has disclosed $10M raised across 1 round.
Where is Ally Therapeutics headquartered?
Ally Therapeutics is headquartered in Cambridge, US.